---
layout: post
title: "微芯生物：西奥罗尼治疗软组织肉瘤II期临床试验申请获批"
date: 2022-03-17 16:10:16 +0800
categories: cailianshe
tags: 财联社新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.688321" data-code="688321|1|1" data-code2="688321|1|23|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.688321&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 688321_0" data-code="K 688321|1|1" data-code2="K 688321|1|23|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>微芯生物公告，公司药品西奥罗尼治疗软组织肉瘤II期临床试验申请获得批准。西奥罗尼胶囊治疗标准治疗失败的晚期或不可手术切除的软组织肉瘤。<br /></p><p class="em_media">（文章来源：财联社）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203172313970195>

[返回财联社新闻](//finews.withounder.com/category/cailianshe.html)｜[返回首页](//finews.withounder.com/)